Prevalence of germline TP53 mutations in HER2+ breast cancer patients

Michelle G. Rath, Serena Masciari, Rebecca Gelman, Alexander Miron, Penelope Miron, Kathleen Foley, Andrea L. Richardson, Ian E. Krop, Sigitas J. Verselis, Deborah A. Dillon, Judy E. Garber

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Prevalence of germline TP53 mutations in HER2+ breast cancer patients'. Together they form a unique fingerprint.

Medicine & Life Sciences